SAM
NDRM

Sandell Asset Management’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Sandell Asset Management’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,128,950
Closed -$43.9M – 50
2017
Q3 		$43.9M Buy
+1,128,950
New +$41.5M 5.03% 7

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Sandell Asset Management's NDRM Position: Q4 2017 in Review

Sandell Asset Management sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 1,128,950 shares — an estimated $43.9M sold.

Sandell Asset Management first reported a position in NDRM in Q3 2017 and held it in 1 quarter. The position peaked at $43.9M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Sandell Asset Management reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Sandell Asset Management sold 1,128,950 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $43.9M.
  • Sandell Asset Management first reported a position in NeuroDerm Ltd. Ordinary Shares in Q3 2017 and held it in 1 quarter.
  • Sandell Asset Management's NeuroDerm Ltd. Ordinary Shares position peaked at $43.9M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Sandell Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.